Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Clinical trial NCT01259089 · COMPLETED
Trial details
- NCT number
- NCT01259089
- Sponsor
- Northwestern University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-27
- Primary completion
- 2013-06-04
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.